Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$767K Sell
6,378
-107
-2% -$12.4K 0.06% 108
2025
Q4
$683K Sell
6,485
-22
-0.3% -$2.06K 0.05% 118
2025
Q3
$546K Sell
6,507
-8,831
-58% -$727K 0.04% 133
2025
Q2
$1.21M Sell
15,338
-723
-5% -$57.5K 0.1% 91
2025
Q1
$1.44M Buy
16,061
+9,380
+140% +$876K 0.13% 76
2024
Q4
$665K Sell
6,681
-8,947
-57% -$922K 0.06% 113
2024
Q3
$1.77M Buy
15,628
+345
+2% +$41K 0.16% 61
2024
Q2
$1.89M Buy
+15,283
New +$1.97M 0.19% 55

Other funds holding MRK

Hardy Reed's MRK Position: Q1 2026 in Review

Hardy Reed reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $12.4K and leaving 6,378 shares worth $767K. The position accounts for 0.06% of the portfolio, ranked #108.

Hardy Reed first reported a position in MRK in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.89M in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hardy Reed held 6,378 shares of Merck worth $767K as of Q1 2026.
  • Hardy Reed sold 107 Merck shares in Q1 2026, an estimated $12.4K.
  • Merck made up 0.06% of Hardy Reed's portfolio in Q1 2026, its #108 holding.
  • Hardy Reed first reported a position in Merck in Q2 2024 and has held it in 8 quarters since.
  • Hardy Reed's Merck position peaked at $1.89M in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.